Phoenix-Based 1606 Corp. Raises $20 Million to Fuel CBD Company Acquisitions
Phoenix’s leading hemp and CBD retail and distribution company, 1606 Corp., has successfully secured an impressive $20 million through an equity financing agreement with GHS Investments. The infusion of funds comes as a major milestone for 1606 as it gears up for ambitious global expansion and strategic acquisitions in the thriving CBD industry.
In a recent press release, 1606’s CEO and Chair, Greg Lambrecht, expressed enthusiasm about the financing, emphasizing its potential to propel the company’s growth by acquiring profitable CBD companies. As a result, 1606 emerges as a highly attractive investment opportunity, appealing to investors worldwide who seek to tap into the lucrative CBD market.
GHS Investments’ involvement in 1606’s equity financing positions them as a strategic partner, acquiring an 80% stake in the company at its current market price. However, the deal comes with an intriguing twist. Upon 1606’s transition from the over-the-counter markets (where it currently trades as CBDW) to a more prominent exchange like Nasdaq, the purchase price will surge to 90% of the market value, with a $2-per-share floor safeguarding investors’ interests.
It’s worth noting that the company has taken a decisive approach, not offering any put options if the share price drops below the $2 threshold. This move exhibits 1606’s strong commitment to its investors and its dedication to maintaining a secure and resilient financial standing even in fluctuating market conditions.
With the newly acquired funding, 1606 Corp. is now ideally positioned to seize the potential growth opportunities in the burgeoning CBD industry. The company’s strategic vision is geared towards acquiring and integrating profitable CBD enterprises, consolidating its market presence, and bolstering its position as a frontrunner in the hemp and CBD retail landscape.
The $20 million financing milestone is just the beginning of an exciting new chapter for 1606 Corp. as it embarks on a journey to expand its global footprint, engage in strategic partnerships, and revolutionize the CBD market. Investors and industry experts alike are closely watching the company’s bold moves, anticipating the transformative impact it will have on the ever-evolving CBD landscape.
